AGY Launches New Glass Fibre Biomaterial for the Medical Device Implant Market

24 January 2009

Due to increasing market demand for higher performing biocompatible composite solutions, AGY has launched a new glass fibre biomaterial reinforcement targeting the medical device implant market.

The new biomaterial, HPB glass fibre, is suitable for long-term implant applications of over 30 days and is compatible with a wide range of thermoplastic polymers such as PEEK, PEI and PPS.

In addition to biocompatibility, HPB glass fibre delivers superior impact, tensile strength and modulus mechanical properties over standard glass fibre products. For example, HPB glass fibres exhibit 40% higher tensile strength and 20% higher tensile modulus versus ordinary E-Glass fibres.

The high elastic resistance of HPB glass fibre enables medical or dental devices to be developed for extended long-term implant requirements. AGY has secured success in multiple composite applications for the oral environment such as orthodontics and dental implants, crowns, and bridges, and is also pursuing other proprietary medical device applications that demand a biocompatible structural composite reinforcement, such as orthopaedics.

HPB glass fibre uses a proprietary glass processing technology and is available in a wide range of chopped, yarn, and roving formats, individually tailored to the demands of the customer. It is part of the S-3 Glass fibre family of special grade products that have properties specifically tailored for high performance applications.

“HPB glass fiber further confirms AGY's strategy to develop advanced materials for a broad range of added value niche applications and market segments worldwide,” said Drew Walker, Vice President Sales and Marketing at AGY.

Share this story